But without reductions in price (hopefully through competition), the current price of these drugs will strain the system
Oral semaglutide is $289/mo month-to-month, or from $249/mo on the 6-month plan, tirzepatide injections at $289/mo (or $249/mo on the 6-month plan), and oral tirzepatide at $349/mo (or $279/mo on the 6-month plan)
Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, et al
Quick look at the key results According to clinical trial investigators, orforglipron: Led to significant weight reduction across all dosing groups Showed greater effects at the highest dose levels Helped lower blood sugar in people with diabetes Supported modest improvements in blood pressure Demonstrated mainly mild to moderate side effects The trial results suggest that the once-daily pill performs competitively with early GLP-1 injection studies
But imagine how much corruption would go unchecked if individuals weren't willing to challenge big corporations and if there weren't lawyers to take them on